Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.581ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.581ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.581EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.581EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.581ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.581ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.330EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.330EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.330ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.330ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.330EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.330EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.330ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.330ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.205EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.205EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.205ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.205ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.205EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.205EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.205ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.205ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.507EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.507EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.507ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.507ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.507EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.507EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.507ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.507ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.178EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.178EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.178ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.178ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.178EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.178EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.178ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.178ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.273EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.273EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.273ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.273ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.273EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.273EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.273ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.273ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.211EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.211EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.211ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.211ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used